Optimizing the procedure for manufacturing clinical-grade genetically manipulated natural killer cells for adoptive immunotherapy

Authors:

Abstract
No abstract available
Funding Information
  • National Natural Science Foundation of China

This publication has 26 references indexed in Scilit: